Assessment of Controversial Pediatric Asthma Management Options Using GRADE

被引:10
作者
Boluyt, Nicole [1 ]
Rottier, Bart L. [2 ]
de Jongste, Johan C. [3 ]
Riemsma, Rob [4 ]
Vrijlandt, Elianne J. L. E. [2 ]
Brand, Paul L. P. [5 ]
机构
[1] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat, NL-1100 DD Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9713 AV Groningen, Netherlands
[3] Erasmus MC, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
[4] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England
[5] Isala Klin, Princess Amalia Childrens Clin, Dept Pediat, Zwolle, Netherlands
关键词
guidelines; asthma; drug therapy; child; evidence-based medicine; glucocorticoids; leukotriene antagonists; bronchodilator agents; INHALED CORTICOSTEROID-THERAPY; ADRENAL AXIS SUPPRESSION; EPISODIC VIRAL WHEEZE; LONG-TERM SAFETY; PRESCHOOL-CHILDREN; FLUTICASONE PROPIONATE; CICLESONIDE; BUDESONIDE; STRENGTH; QUALITY;
D O I
10.1542/peds.2011-3559
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVES: To develop explicit and transparent recommendations on controversial asthma management issues in children and to illustrate the usefulness of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach in rating the quality of evidence and strength of recommendations. METHODS: Health care questions were formulated for 3 controversies in clinical practice: what is the most effective treatment in asthma not under control with standard-dose inhaled corticosteroids (ICS; step 3), the use of leukotriene receptor antagonist for viral wheeze, and the role of extra fine particle aerosols. GRADE was used to rate the quality of evidence and strength of recommendations after performing systematic literature searches. We provide evidence profiles and considerations about benefit and harm, preferences and values, and resource use, all of which played a role in formulating final recommendations. RESULTS: By applying GRADE and focusing on outcomes that are important to patients and explicit other considerations, our recommendations differ from those in other international guidelines. We prefer to double the dose of ICS instead of adding a long-acting beta-agonist in step 3; ICS instead of leukotriene receptor antagonist are the first choice in preschool wheeze, and extra fine particle ICS formulations are not first-line treatment in children with asthma. Recommendations are weak and based on low-quality evidence for critical outcomes. CONCLUSIONS: We provide systematically and transparently developed recommendations about controversial asthma management options. Using GRADE for guideline development may change recommendations, enhance guideline implementation, and define remaining research gaps. Pediatrics 2012;130:e658-e668
引用
收藏
页码:E658 / E668
页数:11
相关论文
共 58 条
[1]  
Adams NP, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003135.pub2, 10.1002/14651858.CD003534.pub2, 10.1002/14651858.CD002310.pub3]
[2]  
[Anonymous], GLOB IN ASTHM GINA
[3]  
[Anonymous], ASTHM CHILDR GUID DE
[4]  
[Anonymous], 2011, BRIT GUIDELINES MANA
[5]   Systems for grading the quality of evidence and the strength of recommendations -: I:: Critical appraisal of existing approaches The GRADE Working Group -: art. no. 38 [J].
Atkins, D ;
Eccles, M ;
Flottorp, S ;
Guyatt, GH ;
Henry, D ;
Hill, S ;
Liberati, A ;
O'Connell, D ;
Oxman, AD ;
Phillips, B ;
Schünemann, H ;
Edejer, TTT ;
Vist, GE ;
Williams, JW .
BMC HEALTH SERVICES RESEARCH, 2004, 4 (1)
[6]   Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing [J].
Bacharier, Leonard B. ;
Phillips, Brenda R. ;
Zeiger, Robert S. ;
Szefler, Stanley J. ;
Martinez, Fernando D. ;
Lemanske, Robert F., Jr. ;
Sorkness, Christine A. ;
Bloomberg, Gordon R. ;
Morgan, Wayne J. ;
Paul, Ian M. ;
Guilbert, Theresa ;
Krawiec, Marzena ;
Covar, Ronina ;
Larsen, Gary ;
Mellon, Michael ;
Moss, Mark H. ;
Chinchilli, Vernon M. ;
Taussig, Lynn M. ;
Strunk, Robert C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (06) :1127-1135
[7]   Budesonide/formoterol maintenance plus reliever therapy -: A new strategy in pediatric asthma [J].
Bisgaard, Hans ;
Le Roux, Pascal ;
Bjamer, Ditlef ;
Dymek, Andrzej ;
Vermeulen, Jan H. ;
Hultquist, Christer .
CHEST, 2006, 130 (06) :1733-1743
[8]   Definition, assessment and treatment of wheezing disorders in preschool children:: an evidence-based approach [J].
Brand, P. L. P. ;
Baraldi, E. ;
Bisgaard, H. ;
Boner, A. L. ;
Castro-Rodriguez, J. A. ;
Custovic, A. ;
de Blic, J. ;
de Jongste, J. C. ;
Eber, E. ;
Everard, M. L. ;
Frey, U. ;
Gappa, M. ;
Garcia-Marcos, L. ;
Grigg, J. ;
Lenney, W. ;
Le Souef, P. ;
McKenzie, S. ;
Merkus, P. J. F. M. ;
Midulla, F. ;
Paton, J. Y. ;
Piacentini, G. ;
Pohunek, P. ;
Rossi, G. A. ;
Seddon, P. ;
Silverman, M. ;
Sly, P. D. ;
Stick, S. ;
Valiulis, A. ;
van Aalderen, W. M. C. ;
Wildhaber, J. H. ;
Wennergren, G. ;
Wilson, N. ;
Zivkovic, Z. ;
Bush, A. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) :1096-1110
[9]   Inhaled corticosteroids reduce growth. Or do they? [J].
Brand, PLP .
EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (02) :287-294
[10]   The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis [J].
Castro-Rodriguez, Jose A. ;
Rodrigo, Gustavo J. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (05) :365-370